Skip to main content

Table 1 Clinicopathologic characteristics of studied patient and expression of SOX9 in NSCLC

From: Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival

  No. (%)
Gender  
Male 103(72.5)
Female 39(27.5)
Age (years)  
≤ 65 89(62.7)
>65 53(37.3)
Pathology  
Squamous cell carcinoma 47(33.1)
Adenocarcinoma 68(47.9)
Adenosquamous carcinoma 27(19.0)
NSCLC histology (AJCC grade)  
I 32(22.5)
II 25(17.6)
III 58(40.8)
IV 27(19.0)
Survival (n = 89)  
Alive 33(37.1)
Dead 56(62.9)
Survial time of low expression  
   Mean 31.70  
   Median 28.50  
Survival time of high expression  
   Mean 24.84  
   Median 24.00  
Expression of SOX9  
Negative 7(4.9)
Positive 135(95.1)
Low expression 68(47.9)
High expression 74(52.1)